Regional hyperthermia for soft tissue sarcoma - a survey on current practice, controversies and consensus among 12 European centers.

Autor: Roohani S; Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health at Charité, Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité (Junior) Clinician Scientist Program, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Ehret F; Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Beck M; Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Veltsista DP; Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Nadobny J; Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Zschaeck S; Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health at Charité, Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité (Junior) Clinician Scientist Program, Berlin, Germany., Abdel-Rahman S; Department of Medicine III, University Hospital Munich, Ludwig-Maximilians-University Munich, Munich, Germany., Eckert F; Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany.; Department of Radiation Oncology, AKH, Comprehensive Cancer Center Vienna, Medical University Vienna, Vienna, Austria., Flörcken A; Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany., Issels RD; Department of Medicine III, University Hospital Munich, Ludwig-Maximilians-University Munich, Munich, Germany., Klöck S; Department of Radiation Oncology, Lindenhofspital Bern, Bern, Switzerland., Krempien R; Clinic for Radiotherapy, HELIOS Klinikum Berlin-Buch, Berlin, Germany.; MSB Medical School Berlin, Fakultät für Medizin, Berlin, Germany., Lindner LH; Department of Medicine III, University Hospital Munich, Ludwig-Maximilians-University Munich, Munich, Germany., Notter M; Department of Radiation Oncology, Lindenhofspital Bern, Bern, Switzerland., Ott OJ; Department of Radiation Oncology, Universitätsklinikum Erlangen, Erlangen, Germany.; Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany., Pink D; Department of Medical Oncology, Helios Klinikum Bad Saarow, Bad Saarow, Germany.; Cinic for Internal Medicine C - Haematology and Oncology, Stem Cell Transplantation and Palliative Care, University Medicine Greifswald, Greifswald, Germany., Potkrajcic V; Department of Radiation Oncology, University Hospital Tübingen, Tübingen, Germany., Reichardt P; Department of Medical Oncology, Helios Klinikum Berlin-Buch, and Medical School Berlin, Berlin, Germany., Riesterer O; Center for Radiation Oncology KSA-KSB, Kantonsspital Aarau, Aarau, Switzerland., Spałek MJ; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Department of Radiotherapy I, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Stutz E; Department of Radiation Oncology, Inselspital Bern University Hospital, University of Bern, Bern, Switzerland., Wessalowski R; Department of Paediatric Haematology and Oncology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany., Zilli T; Department of Radiation Oncology, Oncology Institute of Southern Switzerland (IOSI), EOC, Bellinzona, Switzerland.; Facoltà di Scienze Biomediche, Università Della Svizzera Italiana (USI), Lugano, Switzerland.; Faculty of Medicine, University of Geneva, Geneva, Switzerland., Zips D; Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Ghadjar P; Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Kaul D; Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Publikováno v: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group [Int J Hyperthermia] 2024; Vol. 41 (1), pp. 2342348. Date of Electronic Publication: 2024 Apr 23.